New Study: Ghana Pharmaceuticals & Healthcare Report Q4 2015

Ghana's pharmaceutical and healthcare sectors will continue to garner much interest from international investors given the huge market growth potential. In the short term, however, risks relating to healthcare funding, insurance expansion and economic growth will remain elevated.

Headline Expenditure Projections

Pharmaceuticals: GHS1.01bn (USD329mn) in 2014 to GHS1.18bn (USD318mn) in 2015; +16.5% in local currency terms and -3.3% in US dollar terms. Forecast unchanged from Q 3 15 in local currency terms, but up graded in US dollar terms.
Healthcare: GHS5.80bn (USD1.89bn) in 2014 to GHS6.56bn (USD1.78bn) in 2015; +13.3% in local currency terms and -6.0% in US dollar terms. Forecast in line with Q315.

Risk/Reward Index

In BMI's Q415 Middle East and Africa (MEA) regional Pharmaceuticals & Healthcare Risk/Reward Index, Ghana scores 33.1 points out of 100, below the regional average of 41.1. Ghana has moved up one place to 20th out of a total of 31 countries, posting a better performance in terms of Risks than Rewards. BMI notes that the depreciating Ghanaian cedi is having a negative impact on short-term pharmaceutical market growth, which is a key contributor the country's low score this quarter.

Full Report Details at
- http://www.fastmr.com/prod/1058390_ghana_pharmaceuticals.aspx?afid=301

Key Trends & Developments

A 17-member committee was inaugurated to review the National Health Insurance Scheme in September 2015. The committee is tasked with proposing options for reform, with the review process expected to last five months, according to Health Minister Alex Segbefia.

In July 2015, a number of pharmaceutical companies in Ghana voiced discontent over the continuous importation of anti-retroviral drugs into the country despite improved capacity to manufacture them domestically.

The Ghana Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Ghana Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Ghana pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Ghana, to test other views - a key input for successful budgeting and strategic business planning in the Ghanaian pharmaceutical and healthcare market.
* Target business opportunities and risks in the Ghanaian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Ghana.
* Assess the activities, strategy and market position of your competitors

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Bahrain Pharmaceuticals & Healthcare Report Q4 2015
- Romania Pharmaceuticals & Healthcare Report Q4 2015
- Bulgaria Pharmaceuticals & Healthcare Report Q4 2015
- Peru Pharmaceuticals & Healthcare Report Q4 2015
- Latvia Pharmaceuticals & Healthcare Report Q4 2015